Drugs / Rabies Human Immunoglobulin (HRIG)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT05832073 Comparator | Apr → Dec 2023 | rabies | Changchun BCHT Biotechnology Co. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rabies Human Immunoglobulin (HRIG) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05832073 ↗ |
| Route | Intramuscular | “Administration mode: intramuscular injection of the vastus lateral muscle group.” NCT05832073 ↗ |